ENDRA LIFE SCIENCES INC. (NDRA) Current Ratio
- Current ratio · latest quarter: Value 7.10×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 7.10× | Current assets / current liabilities. $5.59M ÷ $786.58K ≈ 7.10× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 5.59M USD | Assets, Current |
| Current obligations | 786.58K USD | Liabilities, Current |
| Cash and equivalents | 1.74M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 464.98K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.59M | $786.58K | $1.74M | (m) | (m) | (m) | $464.98K | (m) | 7.10× |
| 2026-03-31 | $536.67K | $835.44K | (m) | (m) | (m) | (m) | $456.84K | (m) | 0.64× |
| 2025-12-31 | $967.97K | $750.96K | $762.37K | (m) | (m) | (m) | $382.97K | (m) | 1.29× |
| 2025-09-30 | $1.05M | $800.31K | (m) | (m) | (m) | $0.00 | $252.49K | (m) | 1.31× |
| 2025-06-30 | $1.85M | $576.64K | (m) | (m) | (m) | $0.00 | $281.99K | (m) | 3.21× |
| 2025-03-31 | $2.18M | $565.78K | (m) | (m) | (m) | $0.00 | $223.59K | (m) | 3.85× |
| 2024-12-31 | $3.43M | $605.23K | (m) | (m) | (m) | $0.00 | $269.68K | (m) | 5.67× |
| 2024-09-30 | $4.96M | $814.04K | (m) | (m) | (m) | $2.71M | $279.42K | (m) | 6.10× |
| 2024-06-30 | $6.71M | $1.35M | (m) | (m) | (m) | $2.71M | $300.36K | (m) | 4.97× |
| 2024-03-31 | $1.27M | $1.22M | (m) | (m) | (m) | $2.71M | $521.58K | (m) | 1.04× |
| 2023-12-31 | $3.03M | $903.10K | (m) | (m) | (m) | $2.62M | $360.40K | (m) | 3.36× |
| 2023-09-30 | $6.40M | $2.17M | (m) | (m) | (m) | $2.76M | $419.14K | (m) | 2.95× |
| 2023-06-30 | $8.08M | $2.03M | $4.82M | (m) | (m) | $2.76M | $414.94K | (m) | 3.98× |
| 2023-03-31 | $5.52M | $1.83M | $2.36M | (m) | (m) | $2.74M | $524.03K | (m) | 3.01× |
| 2022-12-31 | $5.38M | $1.70M | (m) | (m) | (m) | $2.64M | $613.96K | (m) | 3.16× |
| 2022-09-30 | $11.56M | $1.71M | $8.02M | (m) | (m) | $2.63M | $636.70K | (m) | 6.78× |
| 2022-06-30 | $14.49M | $1.50M | (m) | (m) | (m) | $2.37M | $785.07K | (m) | 9.64× |
| 2022-03-31 | $10.12M | $1.36M | (m) | (m) | (m) | $1.93M | $833.86K | (m) | 7.45× |
| 2021-12-31 | $12.09M | $1.54M | (m) | (m) | (m) | $1.28M | $791.05K | (m) | 7.83× |
| 2021-09-30 | $14.47M | $1.58M | (m) | (m) | (m) | $1.50M | $747.76K | (m) | 9.18× |
| 2021-06-30 | $16.34M | $1.64M | (m) | (m) | (m) | $1.32M | (m) | (m) | 9.98× |
| 2021-03-31 | $18.35M | $765.83K | (m) | (m) | (m) | $726.61K | $447.95K | (m) | 23.96× |
| 2020-12-31 | $8.21M | $986.66K | (m) | (m) | (m) | $589.62K | $402.91K | (m) | 8.32× |
| 2020-09-30 | $4.78M | $1.40M | (m) | (m) | (m) | $323.21K | $874.07K | (m) | 3.42× |
| 2020-06-30 | $2.28M | $1.24M | (m) | (m) | (m) | $340.69K | $495.32K | (m) | 1.83× |
| 2020-03-31 | $3.77M | $1.55M | (m) | (m) | (m) | $174.94K | $1.24M | (m) | 2.43× |
| 2019-12-31 | $6.54M | $2.07M | (m) | (m) | (m) | $113.44K | $1.28M | (m) | 3.15× |
| 2019-09-30 | $2.98M | $1.85M | (m) | (m) | (m) | $127.83K | $646.88K | (m) | 1.61× |
| 2019-06-30 | $2.95M | $1.37M | (m) | (m) | (m) | $74.28K | $1.01M | (m) | 2.16× |
| 2019-03-31 | $4.38M | $835.23K | (m) | (m) | (m) | $74.28K | $553.00K | (m) | 5.24× |
| 2018-12-31 | $6.95M | $974.58K | (m) | (m) | (m) | $59.44K | $631.47K | (m) | 7.13× |
| 2018-09-30 | $998.61K | $1.07M | (m) | (m) | $12.28K | $0.00 | $750.58K | (m) | 0.93× |
| 2018-06-30 | $2.83M | $751.38K | (m) | (m) | $11.77K | $279.21K | $462.59K | (m) | 3.77× |
| 2018-03-31 | $3.46M | $860.20K | (m) | (m) | $11.77K | $245.96K | $813.72K | (m) | 4.03× |
| 2017-12-31 | $5.88M | $848.21K | (m) | (m) | $6.85K | $191.68K | $780.26K | (m) | 6.93× |
| 2017-09-30 | $7.22M | $312.04K | (m) | (m) | (m) | $131.68K | $228.27K | (m) | 23.15× |
| 2017-06-30 | $7.67M | $162.30K | (m) | (m) | (m) | $133.42K | $132.65K | (m) | 47.27× |
| 2017-03-31 | $265.65K | $1.92M | (m) | (m) | (m) | $40.24K | $303.17K | (m) | 0.14× |
| 2016-12-31 | $195.59K | $1.38M | (m) | (m) | $0.00 | $40.10K | $227.74K | (m) | 0.14× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |